MEDBLESS PHARMACEUTICAL (OPC) PRIVATE LIMITED
MEDBLESS PHARMACEUTICAL (OPC) PRIVATE LIMITED is a UTTAR PRADESH based ONE PERSON COMPANY LIMITED company, Registered at dated 21-MAY-2025 on Ministry of Corporate Affairs(MCA), The Corporate Identification Number (CIN) of MEDBLESS PHARMACEUTICAL (OPC) PRIVATE LIMITED is U46497UP2025OPC224388 and registration number is 224388.
It has been classified as COMPANY LIMITED BY SHARES and is registered under Registar of Companies ROC-KANPUR India. Authorized share capital of MEDBLESS PHARMACEUTICAL (OPC) PRIVATE LIMITED is Rs. 100000 and its paid up capital is Rs. 100000. It aspire to serve in NA activities across the India.
Its Annual General Meeting (AGM) was lastly conducted on and as per the records of Ministry of Corporate Affairs (MCA), its balance sheet was last filed on .
MEDBLESS PHARMACEUTICAL (OPC) PRIVATE LIMITED has 1 directors MOHAMMAD JAWED ALAM,
The registered Email address of MEDBLESS PHARMACEUTICAL (OPC) PRIVATE LIMITED is medblessdelhi@gmail.com and its registered address is KH NO-1320, PLOT NO 25 NEELMANI COLONEY, ARTHALA GHAZIABAD GHAZIABAD UTTAR PRADESH INDIA 201001 UTTAR PRADESH UTTAR PRADESH india 201001.
The current status of MEDBLESS PHARMACEUTICAL (OPC) PRIVATE LIMITED shows as ACTIVE
COMPANY BASIC DETAILS
MEDBLESS PHARMACEUTICAL (OPC) PRIVATE LIMITED
ROC-KANPUR
ACTIVE
U46497UP2025OPC224388
21-MAY-2025
COMPANY LIMITED BY SHARES
NON-GOVERNMENT COMPANY
ONE PERSON COMPANY
100000
100000
CONTACT DETAILS
201001
INDIA
KH NO-1320, PLOT NO 25 NEELMANI COLONEY, ARTHALA GHAZIABAD GHAZIABAD UTTAR PRADESH INDIA 201001
medblessdelhi@gmail.com
DIRECTOR DETAILS
| DIN | Director Name | Designation | Appointment Date | |
|---|---|---|---|---|
| No Records. | ||||
Details Updated by Companies
Quick Links
- All Registered company of UTTAR PRADESH
- Company Registered in UTTAR PRADESH
- All Registered company of GHAZIABAD in UTTAR PRADESH
- Listed Company
- Company Category
- Latest Registered Company
Contact Us for Update Extra Information about your company and services.